Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations · Regulation FD disclosure
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations · Regulation FD disclosure
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 8-K Event Shareholder vote results
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 9 of 19 · 365 filings